Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.
Saved in:
| Title: | Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network. |
|---|---|
| Authors: | Carlucci PM; Department of Medicine, New York University School of Medicine, New York, NY, USA., Preisinger K; Department of Medicine, New York University School of Medicine, New York, NY, USA., Deonaraine KK; Department of Medicine, New York University School of Medicine, New York, NY, USA., Zaminski D; Department of Medicine, New York University School of Medicine, New York, NY, USA., Dall'Era M; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Gold HT; Department of Medicine, New York University School of Medicine, New York, NY, USA., Kalunian K; Department of Medicine, University of California San Diego, San Diego, CA, USA., Fava A; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Belmont HM; Department of Medicine, New York University School of Medicine, New York, NY, USA., Wu M; Department of Medicine, New York University School of Medicine, New York, NY, USA., Putterman C; Azrieli Faculty of Medicine, Zefat, Israel., Anolik J; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Barnas JL; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Furie R; Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA., Diamond B; Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA., Davidson A; Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA., Wofsy D; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Kamen D; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., James JA; Department of Medicine, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Guthridge JM; Department of Medicine, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Apruzzese W; Pfizer Inc, New York, NY, USA., Rao D; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Weisman MH; Department of Medicine, Stanford University, Palo Alto, CA, USA., Izmirly PM; Department of Medicine, New York University School of Medicine, New York, NY, USA., Buyon J; Department of Medicine, New York University School of Medicine, New York, NY, USA., Petri M; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. |
| Corporate Authors: | Accelerating Medicines Partnership in RA/SLE Network |
| Source: | Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 Mar 01; Vol. 64 (3), pp. 1193-1200. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
